EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion

Xuben Wang, Zhuanghao Hou, Qikai Sun, Quanwei Cui, Guirong Shi, Xianghui Du, Ji Liu, Zhigang Nian, Yeben Qian, Guangming Huang, Rongbin Zhou, Zhigang Tian und 4 weitere

Cell Reports · 2026-07 · 45 (7) · 117612

DOI: 10.1016/j.celrep.2026.117612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Xuben Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Immune Response and Immunotherapy, Institute of Immunology, School of Basic Medical Sciences, Center for Advanced Interdiscip…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Histones, Tumor Escape, Insulin-Like Growth Factor Binding Protein 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are known for their cytotoxic and regulatory functions in immune responses. Here, we identify a subset of insulin-like growth factor binding protein 2 (IGFBP2)+ NK cells enriched in liver cancer, exhibiting impaired cytotoxicity and correlating with poor prognosis in patients with liver cancer. The hypoxic tumor microenvironment induces IGFBP2 expression in NK cells. Mechanistically, hypoxia drives lactate accumulation in intratumoral NK cells, promoting histone H3 lysine 18 lactylation (H3K18La) at the IGFBP2 promoter and enhancing IGFBP2 transcription. NK cell-secreted IGFBP2 inhibits the expression of stress-related activating immune ligands (MICA/B and ecto-CRT) on neighboring tumor cells, thereby reducing their sensitivity to cytotoxic immune cells and promoting immune evasion. Antibody-mediated IGFBP2 blockade increases tumor cell sensitivity to cytotoxic immune cells. Additionally, IGFBP2 blockade synergizes with immune checkpoint therapy to enhance anti-tumor efficacy in liver cancer models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalHistonesTumor EscapeInsulin-Like Growth Factor Binding Protein 2Liver NeoplasmsHumansAnimalsCell Line, TumorMiceTumor Microenvironment

Stichwörter der Autor:innen

CP: cancerCP: immunologyhistone lactylationimmune checkpoint-targeted therapyinsulin-like growth factor binding protein 2liver cancernatural killer cell

Substanzen

HistonesInsulin-Like Growth Factor Binding Protein 2IGFBP2 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Immune Response and Immunotherapy, Institute of Immunology, School of Basic Medical Sciences, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, The First Affiliated Hospital o…
  • Key Laboratory of Precision and Intelligent Chemistry, Hefei National Research Center for Physical Sciences at the Microscale, Department of Cardiology, The First Affiliated Hospital of USTC, School of Chemistry and Mat…
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Immunology, School of Basic Medical Sciences, Fudan University, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Medical Oncology, Fudan University Shangha…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Hou, Z., Sun, Q., Cui, Q., Shi, G., Du, X., Liu, J., Nian, Z., Qian, Y., Huang, G., Zhou, R., Tian, Z., Sun, H., Wei, H., Ma, H., & Zheng, X. (2026). Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion. Cell Reports, 45(7), 117612. https://doi.org/10.1016/j.celrep.2026.117612

Vancouver

Wang X, Hou Z, Sun Q, Cui Q, Shi G, Du X, et al. Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion. Cell Reports. 2026;45(7):117612. doi:10.1016/j.celrep.2026.117612

BibTeX
@article{Wang2026,
  author = {Wang, Xuben and Hou, Zhuanghao and Sun, Qikai and Cui, Quanwei and Shi, Guirong and Du, Xianghui and Liu, Ji and Nian, Zhigang and Qian, Yeben and Huang, Guangming and Zhou, Rongbin and Tian, Zhigang and Sun, Haoyu and Wei, Haiming and Ma, Hongdi and Zheng, Xiaohu},
  title = {Histone lactylation-driven intratumoral IGFBP2+ NK cells promote tumor immune evasion},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {117612},
  doi = {10.1016/j.celrep.2026.117612}
}
Kostenlos starten →